Medical Assistance to Population Affected by Kala-azar - Kenya
Project Overview
This WHO-funded health intervention project addressed the deadly Kala-azar disease (Visceral Leishmaniasis) in Kenya's most endemic districts, providing rapid diagnosis, effective treatment, and community education to achieve the national elimination target of less than 1 case per 10,000 population at district level.
Key Objectives
Improve access to rapid diagnostic testing and quality treatment services in all 7 endemic districts
Diagnose at least 640 Kala-azar cases and ensure 80% complete standard treatment protocols
Strengthen disease surveillance systems and establish reporting mechanisms across districts
Sensitize 30,000 community members on Kala-azar prevention, early symptoms, and treatment availability
Beneficiaries
Direct Beneficiaries
640 diagnosed Kala-azar patients receiving treatment and 30,000 people sensitized on disease prevention
Indirect Beneficiaries
5,975,711 people living in the 7 targeted endemic districts benefiting from reduced disease transmission
Impact Metrics
640 people diagnosed with rapid diagnostic tests
512 patients (80%) completed full standard treatment
30,000 community members trained on prevention
7 districts achieved strengthened surveillance systems